When creating groundbreaking health care technology, keeping products user friendly is a necessity. Photo via Getty Images

In the vibrant landscape of startups, the quest to build groundbreaking products can sometimes overshadow the true essence of our existence — to solve problems for our customers.

It's a trap many fall into, often leading to two common outcomes: prolonged product launches stretching over years or an unfortunate mismatch between product and market leading to startup death. But a dynamic solution exists, minimum viable products, or MVPs. MVP has propelled startups to unprecedented success.

A real-life testimony: MVP's power

Imagine a health care-focused at-home testing startup partnered with a major player. The aim: a telehealth support system for the at-home colon cancer screening. Unlike traditional telehealth services, this system required guiding members through a complex process of collecting stool samples accurately.

Challenges presented

  • Develop a user-friendly telehealth solution in five to six weeks on a limited budget and secure a high-stakes multimillion-dollar deal.
  • Carefully integrating telehealth on the existing portal for user-friendly access while aligning seamlessly with user expectations.
  • Address the complexities of Telehealth, including clinician staffing and regulatory adherence.

User Insights

User journeys and interviews confirmed the necessity for guided support during test-taking, but users showed reluctance to navigate the process independently and expressed a preference for customer support over a clinician assistant.

Interestingly, telehealth was not instinctively linked to test support, but rather to medical advice.

The birth of an MVP strategy: a catalyst for innovation

Since the main user problem was the guided support during test-taking, we created the following MVP solutions.

  • Video call integration: Direct video call button under customer support.
  • Guided messaging: Articulate call support purpose.
  • Testing guides: Portal's step-by-step guidance with videos.
  • Video guide in test kit materials.

Our MVP led us to an excellent NPS score and became a guide for our future roadmap.

Next time you build, remember this and embrace the dynamic MVP strategy — create, learn, and reiterate are the cornerstones of success in digital health product management's journey.

Here are four steps for building a successful MVP in telehealth.

  • Identify crucial user problems: Pinpoint your target customers' most pressing issue.
  • Solve a small problem simply: Initiate a straightforward solution to address a minor problem.
  • Plot the user's journey: Map out the user's path through your solution.
  • Prioritize ruthlessly: Discern the key features and prioritize with precision.
------

Tanu Jain is the founder and CEO of Houston-based Digital Health Innovator, a strategic marketing firm for health care products.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston brain health co. secures $6.5M for rare disease study

neuro funding

Houston-based Goldenrod Therapeutics, part of Fannin Partners' portfolio, has announced the initial close of a $6.5 million series seed preferred stock round.

The round was led by Ataxia Ventures and an affiliate of Fannin, according to a news release.

Goldenrod Therapeutics plans to use the funding to support manufacturing, formulation optimization, IND-enabling studies and a Phase I study of its drug to treat brain inflammation, known as 11h.

The study will consider how 11h, which blocks the enzyme PDE4, could treat Friedreich’s ataxia (FA), a rare genetic disease that affects movement, speech and balance. To date, other PDE4 inhibitors have proven to regulate neuroinflammation and neuronal signaling, but have had adverse gastrointestinal side effects or have not reached enough of the central nervous system, according to Goldenrod.

The company says its 11h is expected to have "broad applicability" with limited emetric side effects.

“Our 11h program is a next-generation, orally bioavailable, brain-penetrant PDE4 inhibitor, where researchers overcame longstanding limitations associated with earlier PDE4 inhibitors," Dr. Dev Chatterjee, CEO of Goldenrod, said in the news release. "We believe this creates the potential for a best-in-class therapy for Friedreich’s Ataxia and a potential foundation for development across multiple neurodegenerative and neuroinflammatory disorders.”

11h was first developed at the University of Nebraska Medical Center (UNeMed). Houston-based Fannin Partners in-licensed the product 2020 and landed SBIR Phase I funding to support its initial development for opioid use disorder soon after.

Goldenrod has also received funding to study 11h's effectiveness for multiple sclerosis, methamphetamine addiction and cocaine addiction.

Goldenrod says it is developing 11h to target a variety of neurological and inflammatory conditions, including Alzheimer's disease, multiple sclerosis, ALS, substance use disorders, Batten disease, pain and traumatic brain injury.

27 Houston companies make Fortune 500 for 2026, led by energy giants

Houston HQs

Editor's note: This article has been updated to correct the number of companies based in the Dallas-Fort Worth area.

Houston is a giant among U.S. hubs for corporate headquarters.

The 2026 Fortune 500 lists 27 companies based in the Houston area, with many energy companies claiming top spots. Houston ties with Chicago for the second-most Fortune 500 headquarters, preceded only by New York City (53). Dallas-Fort Worth is home to 24 Fortune 500 headquarters.

Texas leads the nation for Fortune 500 headquarters (57), with California in the No. 2 spot and New York at No. 3.

“Texas is the undisputed headquarters of headquarters,” Gov. Greg Abbott said in a news release. “The world’s leading businesses invest with confidence in Texas because of our welcoming business climate, predictable regulatory environment, and skilled and growing workforce. People and businesses are choosing Texas because Texas works.”

The 2026 Fortune 500 ranks the largest U.S. corporations based on revenue in fiscal year 2025.

Here’s a rundown of the 27 Fortune 500 companies based in the Houston area.

  • No. 9 ExxonMobil
  • No. 21 Chevron
  • No. 29 Phillips 66
  • No.55 Sysco
  • No. 75 ConocoPhillips
  • No. 89 Enterprise Products Partners
  • No. 103 Plains GP Holdings
  • No. 133 Hewlett Packard Enterprise
  • No. 149 NRG Energy
  • No. 157 Quanta Services
  • No. 164 Baker Hughes
  • No. 173 Occidental Petroleum
  • No. 179 Waste Management
  • No. 201 EOG Resources
  • No. 204 Group 1 Automotive
  • No. 207 Halliburton
  • No. 223 Cheniere Energy
  • No. 236 Corebridge Financial
  • No. 262 Targa Resources
  • No. 266 Kinder Morgan
  • No. 388 Westlake
  • No. 435 CenterPoint Energy
  • No. 438 APA
  • No. 440 Comfort Systems USA
  • No. 455 NOV
  • No. 488 KBR
  • No. 496 Coterra Energy. Oklahoma City, Oklahoma-based Devon Energy and Houston-based Coterra Energy merged in early May, with the combined company retaining the Devon Energy name and the Houston headquarters.

The Greater Houston Partnership notes the Houston area soon will welcome its 28th Fortune 500 company. Expand Energy (formerly Chesapeake Energy), appearing at No. 362 on the 2026 list, says it’s moving its headquarters from Oklahoma City to Spring this year.

As the natural gas producer prepares to relocate to Texas, it’s hunting for a new leader. Nick Dell’Osso stepped down as president and CEO earlier this year. Board Chairman Michael Wichterich is interim president and CEO.

Dell’Osso became president and CEO of Oklahoma City-based Gulfport Energy effective May 28.

---

This article first appeared on EnergyCapitalHTX.com.